Transcatheter Mitral and Tricuspid Valve Therapies

Transcatheter mitral and tricuspid valve therapies are emerging as promising alternatives to traditional surgical approaches for managing valvular heart diseases. These minimally invasive techniques offer treatment options for patients who are high-risk surgical candidates. Recent innovations, including edge-to-edge repair and valve replacement procedures, have shown significant improvements in symptoms and quality of life. Ongoing clinical trials are assessing the safety and effectiveness of these interventions, aiming to refine techniques and expand indications. As these therapies develop, they represent a vital advancement in the management of mitral and tricuspid valve disorders.

    Related Conference of Transcatheter Mitral and Tricuspid Valve Therapies

    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Transcatheter Mitral and Tricuspid Valve Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in